Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras1
- 1 May 2002
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 73 (9) , 1487-1493
- https://doi.org/10.1097/00007890-200205150-00020
Abstract
Recent progress in allogeneic hematopoietic stem cell transplantation provides new methods for reliable engraftment with nonlethal conditioning regimens. These techniques have been successfully applied in the treatment of both malignant and nonmalignant diseases, but have not been fully exploited for their potential to tolerize recipients for organ transplantation. These studies were undertaken to test whether the tolerance of host immune cells toward donor hematopoietic cells in mixed hematopoietic chimeras extends to include a vascularized organ, the kidney. Using nonmyeloablative doses of total body irradiation, a short course of immunosuppression, and hematopoietic stem cells from marrow or peripheral blood sources, five dog lymphocyte antigen-identical canines were made to become stable mixed hematopoietic chimeras with no development of graft-versus-host disease or posttransplant lymphoproliferative disorder. Subsequently, renal transplantations were performed between stem cell donor and recipient littermates, and no additional immunosuppressive therapy was given after stem cell transplantation. All mixed chimeric dogs demonstrate different, but stable, levels of donor peripheral blood lymphocyte and granulocyte chimerism. With follow-up of longer than 1 year, all of the mixed chimeric dogs (five/five) have excellent renal function with normal serum creatinines (<1.5 mg/dl) and no pathological evidence of rejection on biopsies. In a major histocompatibility-matched model, minor antigen differences between donor and recipient are not sufficient to induce a host immune response to a vascularized kidney transplant in mixed hematopoietic chimeras.Keywords
This publication has 35 references indexed in Scilit:
- Mixed chimerism induced without lethal conditioning prevents T cell– and anti-Galα1,3Gal–mediated graft rejectionJournal of Clinical Investigation, 1999
- MINOR TRANSPLANTATION ANTIGENSTransplantation, 1998
- Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.Journal of Clinical Investigation, 1996
- USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTINGTransplantation, 1994
- Expression of human minor histocompatibility antigen on cultured kidney cellsEuropean Journal of Immunology, 1993
- Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expressionCell, 1991
- Cellular immunity in allograft rejection: Role of lymphocyte subpopulations and T-cell subsets in rat cardiac allograft rejectionCellular Immunology, 1989
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- TRANSPLANTATION OF STORED ALLOGENEIC BONE MARROW IN DOGS SELECTED BY HISTOCOMPATIBILITY TYPINGTransplantation, 1969
- ALLOGENEIC CANINE BONE MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDETransplantation, 1969